Richard L. Beard,Vidyasagar Vuligonda,Thong Huy Vu,Michael E. Garst
申请号：
US15112623
公开号：
US09920013B2
申请日:
2015.01.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to 1-(2,5-dioxoimidazolidin-1-yl)-3-substituted urea compounds, processes for preparing them, pharmaceutical compositions containing them, their use as pharmaceuticals as modulators of the FPR2 receptor, and to methods of treating inflammatory diseases or conditions in a subject in need thereof by administering the compound(s) or pharmaceutical composition to the subject.
